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The inter-ministerial conference on immunization held at African 
Union headquarters in February 2016 came, by coincidence, almost 
exactly 30 years after the first international immunization 
conference I attended, convened by World Health Organization 
(WHO) and UNICEF in Mbabane in December 1985. Times have 
changed. In 1985, there was no Gates Foundation, there was no 
Global Vaccine Alliance (GAVI Alliance), and there was no global 
commitment to polio eradication. Three items which figured 
prominently on the Addis Ababa program were quite absent from 
many earlier meetings: 1) the economic justification for vaccination 
and eradication; 2) the role of parliamentarians, religious leaders 
and civil society organizations (CSOs) in advocacy and accountability 
for vaccination programs, 3) vaccine financing. 
  
The economic justification for vaccination 
and eradication 
  
Economists were not much to be seen in the vaccination programs 
of 30 years ago. Vaccination, like virtue, was thought to be its own 
reward. This assumption was based on the erroneous premise that 
finance ministers would support vaccination programs because they 
were a global public good, like clean air. The multiple calls on scarce 
public resources have generated much academic work to build the 
case for vaccination. The most quoted figure from the Addis Ababa 
conference was based on the published work of Ozawa and 
colleagues, from Johns Hopkins, showing a benefit: cost ratio of 
16:1 for childhood vaccinations in low- and middle-income 
countries. Their work [1] is a powerful advocacy tool for use with 
hard-nosed finance ministers, who must say no to health ministries 
as often as they say yes. 
The conference coincided with the publication of a newspaper 
interview by Wycliffe Muga with Dr. Kimberly Thompson on the 
subject of disease eradication [2]. 
  
Parliamentarians, CSOs and religious 
leaders 
  
Thirty years ago, vaccination was a program to be managed by 
national health ministries with the support of international agencies, 
especially W.H.O. and UNICEF. That model worked poorly because 
it assumed that governments always act in the interest of their 
citizens. When governments cut corners, it is often at the expense 
of their most vulnerable citizens, especially children. 
  
Civil society organizations and parliamentarians, formerly marginal 
players in immunization, have assumed growing importance in 
assuring that governments adhere to their commitments properly to 
finance and support health services in general, and immunization in 
particular. 
  
This need is all the more pressing as vaccines used and vaccine 
procurement bills have seen an astronomical rise. Under these 
conditions, it is not surprising that 9 African countries are in default 
on their co-payments for internationally procured vaccines. When 
this information becomes widely known, pressure builds on 
governments to take corrective measures. 
  
One parliamentarian from Kinshasa illustrated the point during the 
Addis Ababa conference. 
  
“When the Prime Minister says the co-financing is done, I phone 
UNICEF. If UNICEF does not confirm, I phone him again.” 
  
The role of religious leaders in vaccination became clear during the 
Nigerian vaccination boycott of 2003, which slowed the elimination 
of polio from that country, only polio free since 2014. The Sultan of 
Sokoto, speaking at the Addis Ababa conference, serves as chair of 
the Council of Traditional Rulers. Speaking in Addis Ababa, he said 
the following about the vaccine boycott. 
  
“Nigeria had a role in the fight against polio, especially the OPV 
boycott, until the traditional leaders intervened in favor of the polio 
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campaigns. The people of Nigeria give a lot of respect to their 
religious leaders. Our intervention is on the positive side. Our 
common enemy was polio. With the Federal Ministry of Health, I 
worked on this issue. When I say “religious leaders,” I mean both 
Muslims and Christians. When you work together, setting aside your 
divisions, you can solve the problem and make the lives of Nigerians 
much better.” 
  
Among most Christians, there has been general support for 
vaccination, as illustrated by Pope Francis‟ recent participation in 
Mexico‟s success polio vaccination project (see photo). Where 
opposition has appeared, as on the part of the Kenyan Episcopal 
Conference, it has been generally sporadic. Health education among 
Catholic and non-Catholic communities has in the case of Kenya 
blunted the edge of the bishops‟ campaign (unpublished data, Dr. 
Collins Tabu, Kenyan Ministry of Health). 
  
In the 21st as in the 20th century, health services provided by faith 
based organizations have been a point of entry for vaccination and 
other child health services, sometimes providing vaccination services 
in places where government health services have broken down. In 
the Zaïre of Mobutu, the largest vaccine cold chain in Mayumbe was 
run from the mission hospital in Kangu. With reliable standby 
generators, it was the only hospital in Mayumbe with reliable power 
supply 24/7 during the late „70s. 
  





The world‟s vaccine bill is on the rise, as countries which used to 
vaccinate against six diseases now vaccinate against 10 to 12 
diseases with vaccines which, at as much $5 a dose, are far less 
affordable than in the past. Thirty years ago, the Republic of Kenya 
had a vaccine bill for its routine vaccines (BCG, measles, DPT, OPV 
and TT) of < $1 million. Today, Kenya‟s bill for 11 vaccines exceeds 
$20 million, most of it for new and under-used vaccines co-financed 
by the Kenyan government and international partners. 
  
The cost of vaccines is especially tragic in the fight against cancer. 
Hep B vaccine, available from multiple suppliers at low prices, is 
now given in all African countries. Impact studies have shown 
significant declines in Hep B prevalence among early adopters of 
Hep B vaccine, and liver cancer is likely to show similar declines in 
future decades. For HPV, human papillomavirus vaccine, Rwanda, in 
sub-Saharan Africa, has introduced this vaccine on a national scale, 
and that with full external funding. Most other African countries 
have introduced HPV on a sub-national scale, or not at all. 
Meanwhile, cervical cancer remains a major cause of death among 
women of child bearing age. 
  
The international community has increased its spending on 
vaccines, as have developing countries. But gaps remain. Donal 
Brown, speaking for one major donor (DFID), made the following 
comments from a partner perspective. 
  
“There is enormous competition for donor resources. Everything is a 
priority, but you can‟t fund anything. Spending on humanitarian 
relief last year was the highest in history. EPI competes with other 
priorities. 
  
The Johns Hopkins benefit: cost figure of 16:1 comes to 44:1 when 
you incorporate all benefits. Immunization is the best buy. It is, 
therefore, something that developing countries should be willing to 
finance. We‟ve looked at costs of immunization as a part of 
government expenditure. Most countries can pay for vaccination. It 
is a question of choice. There is a role here for community service 
organizations (CSOs). Revenues of African governments have 
almost tripled in the last decade. Donors cannot fill that gap. GAVI 
graduation policy (for countries with per capita GNI greater than 
USD 1500) is well considered. 
  
It‟s a question of willingness to pay, not ability to pay. We need 
better engagement between finance ministries and health ministries. 
It‟s not a donor issue.” 
  
Pooled procurement of vaccines, as in the Region of the Americas, 
was discussed by some participants in Addis Ababa. Another 
possible solution raised was the production of WHO prequalified 
vaccines in Africa. This is already done, by the Pasteur Institute of 
Dakar, for yellow fever vaccine. Chris Elias, of the Gates Foundation, 
suggested the following considerations on local vaccine production 
in Africa: 1) Regulatory environment. The regulatory hurdles are 
high for vaccines. Even successful companies stumble at times, 
sometimes losing their W.H.O. prequalification status, 2) India and 
China have had a long path. They had a large domestic population 
as their first market. Senegal has long been a prequalified supplier 
of yellow fever vaccine. Here in Ethiopia, The Bill and Melinda Gates 
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Foundation (BMGF) has been working on production of veterinary 
vaccines, costing $50 million. The regulatory challenge is lower for 




With polio eradication in perspective, African countries are 
beginning to look for new targets for elimination, including measles 
and, perhaps, rubella. What are the preconditions to be met? The 
ideas emerging from the Addis Ababa conference pointed to the 
following imperatives: 
 National political and economic commitments from health 
and finance ministries 
 Uninterrupted financing of vaccine and local currency 
costs of vaccination from national and international 
partners 
 Full participation in vaccination by religious leaders, CSOs, 
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